Get started

Cannabis

Descending Channel for TLRY?It appears though Tilray, TLRY on NASDAQ is trading in a descending channel. A bounce to the downward sloping resistance of the pattern is expected near term, the company is a pump machine with the PRs, Irwin has his eyes on more than Hexo, so in my opinion, the company will continue M&A, and has the rights to change the terms of agreement with Hexo pending due diligence. Watch out for the DMI, currently trading neutral, if the blue line breaks above the orange a breakout to the upside is either near term or occurring in real-time, and on the contrary, if the blue line on the DMI crosses the red to the downside hold your ankles. If history is to repeat itself, the RSI has called the micro top of each bounce to the upside inside the descending channel. A descending channel is drawn by connecting the lower highs and lower lows of a security's price with parallel trendlines to show a downward trend. Officially, the space between the trendlines is the descending channel, which falls under the broad category of trend channels. A descending channel is drawn by connecting the lower highs and lower lows of a security's price with parallel trendlines to show a downward trend. Traders who believe a security is likely to remain within its descending channel can initiate trades when the price fluctuates within its channel trendline boundaries. A more potent signal occurs with a breakout, which is when a security's price breaches an established channel's boundaries, either on the upper or lower side. Trading range for the foreseeable future between 9 Dollars & 3 Dollars. The volatility of the market is likely to cause fake-outs in both directions, trade accordingly.
NASDAQ:TLRY
by ScotianBot
HEXO, A PATH TO $1 - SELL BEFORE 4/20?I've been watching this stock for awhile now and I think we've finally hit that point where a turnaround happened. Look, Cannabis is going to be a big industry, but it's a matter of how long. Now Hexo has 180 days to climb back over $1 and the question becomes, "can they do it?" From what I've seen in the charts, I feel we might see a pump pretty soon, sometime before april, which will unfortunately allow the stock to drop right around 4/20, giving it a chance to settle around $1 before the 180 days are up. Good news, if you catch the drop right, there might be a chance to ride Hexo back up to around $2.70-$3.00 long term and then close to $5 per share even longer term. Does anyone else still watch this stock or am I the only one?? Let me know if you are seeing another scenario play out in the comments.
HLong
by nicktussing77
4
$TLRY smoking on that tilray pack 👁‍🗨*This is not financial advice, so trade at your own risks* *My team digs deep and finds stocks that are expected to perform well based off multiple confluences* *Experienced traders understand the uphill battle in timing the market, so instead my team focuses mainly on risk management Recap: The market has been in loading zone the past couple of weeks. My team is loading up shares of companies that we believe are likely to benefit from this rally. Today before the market closed my team purchased shares of marijuana company Tilray Brands $TLRY at $6.26 per share. Our take profit is $10 ENTRY: $6.26 TAKE PROFIT: $10 (OPTIONAL) STOP LOSS: $5.50 If you want to see more, please like and follow us @SimplyShowMeTheMoney
NASDAQ:TLRYLong
by SimplyShowMeTheMoney
SNDL 180-Day Extension by Nasdaq to Regain ComplianceSNDL Sundial received an extension of 180 calendar days to regain compliance with Nasdaq's minimum $1 bid price requirement. SNDL needs to close at or above US$1.00 per share for a minimum of 10 consecutive trading days before August 8, 2022, which most likely should happen sooner. Let`s just remember how SNDL stock was trading at $3.96 one year ago around the same date. But the company made progresses and the Alcanna buyout should take Sundial Growers Stock back to $1. The investors were scared because of a possible dilution or delisting from Nasdaq for non-compliance. Now it should also regain trust from investors and see it touching the $1.30 resistance soon.
NASDAQ:SNDLLong
by TopgOptions
2
to catch a falling leaf pt.2I truly believe MSOs will bottom out at some point this year... if not already. Whether by way of a market wide dump during a correction, or by forming the bottom of a cup in an eventual cup and handle formation. I think the MSOs have some real world catalysts in place to start turning positive (SAFE Banking Act, more states legalizing, actual positive net income...) whereas the canadian growers are basically crossing their fingers for US legislation to pass while they bleed cash. As with the canadian pot stocks tho, we want to really see this thing shallow out. The current downward trend is trudging along the 1/1 angle, but we need to start seeing local bottoms form on the 2/1 angle. If that happens, we'll likely see some kind ending diagonal form which would indicate wave C is finally coming to a close. The other scenario is that this overheated market takes a dump and pot stocks go along w/ it... (see 2 yrs ago) in which case BTFD and hang on. Ironically it's been the democrats that have been blocking SAFE from being passed into law... apparently looking like awesome social justice warriors is paramount in this endeavor. With their grip on Congress in question in the coming mid-terms they need to cut the crap and hustle to get something done. Expect a bump when SAFE passes as institutions start to get involved in the MSOs. for fun only, not advice.
AMEX:MSOSLong
by chinawildman
1
CNBX leader in cancer related cannabinoid-based medicineCNBX Cannabics Pharmaceuticals has an agreement with Purisys, a leading Active Pharmaceutical Iingredient manufacturer, to use its API in Phase I/II (a) clinical studies that it is planning to launch in 2022. So this year will be quite bullish for CNBX Cannabics Pharmaceuticals is a U.S. public company and a global leader in the development of cancer related cannabinoid-based medicine. It engages in the discovery, development and commercialization of novel cannabinoid-based products and innovative technologies for the treatment of cancer. 52 Week Range 0.08 - 0.60 Market Cap 15.163M Short term upside: $0.20 After they begin the Phase I/II (a) clinical studies, the stock can reach once again its 52 week highs.
OTC:CNBXLong
by TopgOptions
SNDL Sundial Price TargetsIf you haven `t bough the stock here, at 0.57usd: then you should know that Malta became the first European Union member to legalize recreational use and growth of marijuana. Democrats overwhelmingly support legalization for both medicinal and recreational purposes of marijuana. If the U.S. market open up, it could be a boon for SNDL stock. My price targets for SNDL are 0.93 for January an 1.25 for February 2022. Looking forward to read your opinion about it.
NASDAQ:SNDLLong
by TopgOptions
1
#SNDL Just a matter of TIME ⏱️ before jumping higher🔥 Keep calmHi All, my main 3 take-outs from this analysis are the following: 1- 0.59$ level confirms to be a strong support and the price is reacting well from there just now. 2- Moreover, this support level represents to me the neckline of a reversal head & shoulder, which has been broken on Dec 17th with huge volumes at the opening. And it looks like the price is trying a pullback just at the neckline. 3- The target f this technical pattern should be at around 0.65$ and I strongly believe that it might reach this level soon, confirming the completion of another pattern, which would be a double bottom (with the two bottoms being the one of Dec 6th and Dec 15th Not a financial advice, just personal opinion. Do your own due diligence and good luck!
NASDAQ:SNDLLong
by FrancescoMerlettini
4